SELLAS Life Sciences Group, Inc. (SLS) Analyst Estimates Annual - Discounting Cash Flows
SLS
SELLAS Life Sciences Group, Inc.
SLS (NASDAQ)
Period Ending: 2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-30
2021
12-30
2015
12-30
Number of Analysts 1 2 2 2 1 0 2 1 1 1
Estimated Revenue
Low 293.3 123.6 45.74 36.13 31.98 0 13 1 5.07 8.29
Average 293.3 123.6 45.74 36.13 31.98 0 13 1 5.07 8.29
High 293.3 123.6 45.74 36.13 31.98 0 13 1 5.07 8.29
Estimated EBITDA
Low -58.66 -24.73 -9.15 -7.23 -6.4 0 -2.6 -0.2 -1.01 -1.66
Average -58.66 -24.73 -9.15 -7.23 -6.4 0 -2.6 -0.2 -1.01 -1.66
High -58.66 -24.73 -9.15 -7.23 -6.4 0 -2.6 -0.2 -1.01 -1.66
Estimated EBIT
Low -58.66 -24.73 -9.15 -7.23 -6.4 0 -2.6 -0.2 -1.01 -1.66
Average -58.66 -24.73 -9.15 -7.23 -6.4 0 -2.6 -0.2 -1.01 -1.66
High -58.66 -24.73 -9.15 -7.23 -6.4 0 -2.6 -0.2 -1.01 -1.66
Estimated Net Income
Low 100.4 -3.06 -15.91 -19.38 -15.91 -32.85 -616.1 -1,284 -818.6 -5,471,495
Average 100.4 12.32 -10.4 -19.38 -15.91 -32.85 -616.1 -1,284 -818.6 -5,471,495
High 100.4 18.36 -4.9 -19.38 -15.91 -32.85 -616.1 -1,284 -818.6 -5,471,495
Estimated SGA Expenses
Low 1,239 522.3 193.2 152.7 135.1 0 54.92 4.22 21.41 35.02
Average 1,239 522.3 193.2 152.7 135.1 0 54.92 4.22 21.41 35.02
High 1,239 522.3 193.2 152.7 135.1 0 54.92 4.22 21.41 35.02
Estimated EPS
Low 1.64 -0.05 -0.26 -0.317 -0.26 -0.537 -1.01 -2.1 -1.34 -8,940
Average 1.64 0.125 -0.173 -0.317 -0.26 -0.537 -1.01 -2.1 -1.34 -8,940
High 1.64 0.3 -0.08 -0.317 -0.26 -0.537 -1.01 -2.1 -1.34 -8,940
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program